Literature DB >> 8131854

The 3D structure of a cyclosporin analogue in water is nearly identical to the cyclophilin-bound cyclosporin conformation.

R M Wenger1, J France, G Bovermann, L Walliser, A Widmer, H Widmer.   

Abstract

The conformation of [D-MeSer3-D-Ser-(O-Gly)8]CS, a water soluble cyclosporin derivative, has been determined in (D6)DMSO and in water using NMR. In these polar solvents the conformation is identical and very similar to the structure found in the cyclophilin-cyclosporin complex. However, it differs significantly from its conformation in deuterated chloroform. This demonstrates unambiguously that the large structure change is induced primarily by the polar solvent rather than by complex formation with cyclophilin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8131854     DOI: 10.1016/0014-5793(94)80149-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  6 in total

Review 1.  Repurposing of cyclophilin A inhibitors as broad-spectrum antiviral agents.

Authors:  Jinhe Han; Myoung Kyu Lee; Yejin Jang; Won-Jea Cho; Meeheyin Kim
Journal:  Drug Discov Today       Date:  2022-05-21       Impact factor: 8.369

2.  Modeling conformational changes in cyclosporin A.

Authors:  M F O'Donohue; A W Burgess; M D Walkinshaw; H R Treutlein
Journal:  Protein Sci       Date:  1995-10       Impact factor: 6.725

Review 3.  Getting in shape: controlling peptide bioactivity and bioavailability using conformational constraints.

Authors:  Jonathan E Bock; Jason Gavenonis; Joshua A Kritzer
Journal:  ACS Chem Biol       Date:  2012-11-30       Impact factor: 5.100

4.  Cyclosporin A in Membrane Lipids Environment: Implications for Antimalarial Activity of the Drug--The Langmuir Monolayer Studies.

Authors:  Patrycja Dynarowicz-Łątka; Anita Wnętrzak; Katarzyna Makyła-Juzak
Journal:  J Membr Biol       Date:  2015-06-16       Impact factor: 1.843

5.  V101L of human formyl peptide receptor 1 (FPR1) increases receptor affinity and augments the antagonism mediated by cyclosporins.

Authors:  Caihong Zhou; Yan Zhou; Jia Wang; Yang Feng; Haonan Wang; Jinglun Xue; Yani Chen; Richard D Ye; Ming-Wei Wang
Journal:  Biochem J       Date:  2013-04-15       Impact factor: 3.857

6.  Conformation of the Macrocyclic Drug Lorlatinib in Polar and Nonpolar Environments: A MD Simulation and NMR Study.

Authors:  Cheng Peng; Yoseph Atilaw; Jinan Wang; Zhijian Xu; Vasanthanathan Poongavanam; Jiye Shi; Jan Kihlberg; Weiliang Zhu; Máté Erdélyi
Journal:  ACS Omega       Date:  2019-12-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.